Intra-Cellular Therapies Inc (ITCI) Company Profile & Statistics

Intra-Cellular Therapies Inc
ITCI
(Nasdaq - US)
Closed
85.43
-0.21 (-0.24%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
85.58
High
85.70
Low
84.49

About Intra-Cellular Therapies Inc

CEO

Sharon Mates

Headquarters

430 east 29th street

new york, ny 10016, united states

Auditor

Ernst & Young LLP

Employees

610

Share Holders

Website

www.intracellulartherapies.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.

Intra-Cellular Therapies Inc Statistics

Valuation Measures

Market Capitalization ²	9.06B
Enterprise Value	8.59B
Enterprise Value/EBITDA (ttm)	-66.26
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	7.72
Price to Sales (ttm)	14.40
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	92.33%
Operating Margin (ttm)	-14.07%
Profit Margin (ttm)	-14.30%
Return on Equity (ttm)	-9.93%
Return on Invested Capital (ttm)	-11.09%
Return on Assets (ttm)	-8.38%

Income Statement

Revenue (ttm)	613.73M
Revenue Per Share (ttm)	5.79
Gross Profit (ttm)	566.47M
EBITDA (ttm)³	-129.67M
Net Income Avi to Common (ttm)	-86.37M
Diluted EPS (ttm)	-0.87

Share Statistics

Beta (5Y Monthly)	0.97
52-Week Change	45.88%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	106.02M
Dividend Yield	0.00%
Float ⁴	103.26M
% Held by Insiders	2.60%
% Held by Institutions	92.33%

Balance Sheet

Total Cash (mrq)	1.01B
Total Cash Per Share (mrq)	9.51
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	7.66%
Quick Ratio (mrq)	7.51%
Book Value Per Share (mrq)	10.80

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.57
Free Cash Flow (ytd)	-60.85M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Intra-Cellular Therapies Inc

Trade With A Regulated Broker